Rates of Guideline-concordant Surgery and Adjuvant Chemotherapy use in Early-stage Non-small Cell Lung Cancer Patients

Summary

Project ID: 2022-956 / TRIM 2023 0970 318 000

Principle Investigator: Rosalyn Juergens

Description: The project team is interested in accessing ICES data for patients in Ontario with early-stage (IB to IIIA) non-small cell lung cancer, and obtaining data on treatments received (surgery, adjuvant chemotherapy, etc.). Furthermore, the project team will investigate predictors for receiving guideline recommended treatments (e.g. age, sex, race/ethnicity, cancer stage, smoking history, medical co-morbidities, education level, marital status, geography, etc.).

The project team will aim:

1. To identify rates of adherence to guideline recommended surgery, adequate lymph node dissection, and adjuvant chemotherapy for early-stage (stage IB to IIIA) patients with non-small cell lung cancer.
2. To identify any predictor(s) for poor adherence to guideline recommended treatments.

PIA Approved: August 24, 2022